Harbour BioMed, a worldwide biopharmaceutical business, announced that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to start the first-in-human (FIH) clinical study in the US for bispecific...
Zydus Lifesciences said that it has gained FDA permission to offer a generic medicine to treat postherpetic neuralgia. Zydus Lifesciences announced in a regulatory filing that the US Food and Drug Administration (USFDA) has granted final...
Although prevention is essential, treatment of obesity classes 2 to 3 defies traditional methods with a success rate of 1 in 100 and is not surgically feasible for everyone due to surgical complications.
Glenmark Pharmaceuticals Ltd said its subsidiary Glenmark Specialty SA (GSSA) has entered into a licensing agreement with Jiangsu Alphamab Biopharmaceuticals Co and 3D Medicines (Beijing) Co Ltd for KN035 (Envafolimab),
Ferns N Petals, India's leading luxury brand, has announced the launch of 'MediJourney'. The world's new health tourism sector.
Research-based motivators to foster imaginative medications can assist the innovative drug area with being worth USD 200 billion by 2030, Biocon Chief Director Kiran Mazumdar-Shaw said. She noted that the pharmaceutical sector has even greater...
Venus Remedies has been awarded a Good Manufacturing Practice (GMP) certificate for its facilities by the Libyan Ministry of Health. Libya's pharmaceutical imports, estimated at $514 million in 2021, increased by 2.81 percent compared to the...
Galytix, a GenAI platform, and Foyer Global Health, an international health insurance company of foreign companies, have announced a collaboration to present HealthX, a digital health platform for insurance companies. The International Private...
Early-stage biotechnology company Virios Therapeutics, Inc. announced plans to use IMC-2 (a combination of valacyclovir and celecoxib) to treat fatigue, orthostatic intolerance and other symptoms of LC (also known as post-acute). Consequences of...
AstraZeneca Pharma India Ltd has announced that it has received approval from the Indian Standard Drugs Control Organization (CDSCO) to import and market Andexanet Alfa. FXa inhibitors are used to prevent and treat thrombotic events such as deep...
, CDSCO.jpg)
